Demo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase onlyDemo mode: simulated data, for showcase only
64%chance
Wegovy, including the new HD 7.2 mg dose, anchors Novo's obesity sales. Resolves YES if Novo reports full-year 2026 Wegovy revenue above DKK-equivalent US$10 billion. Source: Novo Nordisk annual report.
This is going to move hard when people wake up to this.
What's everyone's thesis here? I'm undecided.
I think people are overreacting. This won't happen.
Just saw the news - this changes everything!
This is my largest position. Very confident.
Anyone else think this is overvalued right now?
This is my largest position. Very confident.